A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
Novartis
Novartis
Nurix Therapeutics, Inc.
Context Therapeutics Inc.
Telix Pharmaceuticals (Innovations) Pty Limited
PharmaMar
Medicenna Therapeutics, Inc.
Instituto do Cancer do Estado de São Paulo
Multitude Therapeutics Inc.
Abramson Cancer Center at Penn Medicine
Swiss Cancer Institute
National Cancer Institute (NCI)
National Cancer Institute (NCI)
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)